🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures

Recruitingn/aAges 18 Years - anyAllChristian S. Meyhoff
NCT06289699 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this prospective, international multi-centre pilot study is to assess the functionality and user experience of a new vital sign monitoring system in 20 patients and 20 nurses in the general ward at each centre. The patients will be monitored with a wireless, continuous vital sign monitoring systems and answer a questionnaire afterwards. They will in addition have vital signs monitored as per standard practice. The nurses will answer a questionnaire after having had the responsibility for a monitored patient for a full shift. The main aims are: To determine the frequency of alerts activated in the app in relation to the alerts that should be activated based on measured data, to explore current practices of in-hospital monitoring by semi-structured interviews to map differences across systems and to test nurse and patient satisfaction.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults (≥18 years) * Expected stay in the hospital ≥2 days * Admitted for surgery with expected duration of surgery \>2 hours or admitted for acute medical condition with at least one of the following vital sign deviations within 24 hours of acute admission, recorded by the staff * RR \> 21 breaths pr minute * RR \< 11 breaths pr minute * Pulse (P) \> 91 beats pr minute * Pulse (P) \< 50 beats pr minute * SpO2 \< 94 % without oxygen supplementation * Systolic BP \< 110 mmHg * Systolic BP \> 220 mmHg Exclusion Criteria: * Participant expected not to cooperate with study procedures. * Allergy to plaster or silicone. * Pacemaker or Implantable Cardioverter Defibrillator (ICD) device. * Inability to give informed consent.
💊

What it tests

  • Not listed
📍

Where

5 sites
The Cleveland Clinic Foundation, General Anesthesiology
Cleveland, United States
Universitätsklinikum Hamburg-Eppendorf (UKE), Zentrum für Anästhesiologie und Intensivmedizin, Klinik und Poliklinik für Anästhesiologie
Hamburg, Germany
University Medical Center Groningen, Department of Anesthesiology
Groningen, Netherlands
St. Olavs Hospital HF, Klinikk for anestesi og intensivmedisin
Trondheim, Norway
Liverpool University Hospitals NHS Foundation Trust
Liverpool, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy